Mr. Randy Scott is a Co-Founder and serves as a Partner at HealthQuest Capital. He is an Angel Investor. He serves as a Board Member at Magnolia Medical Technologies. After a successful career as a MedTech entrepreneur, he switched careers because he also saw the opportunities overlooked by investors and felt he could help innovative young businesses by applying the lessons he learned by leading those kinds of companies. He is currently on the board of HealthQuest portfolio companies Vestagen, Virmedica and Avizia and is a Board observer on Magnolia Medical, Trice Medical and FAST. His industry successes include starting NovaMin Technology, Inc. leading it through financing, growth and eventual acquisition by GlaxoSmithKline (at a 10x return on capital); a turn-around of USBiomaterials Corp's bone-grafting business from perennial money-loser to a profitable spin-out (now NovaBone Products); and a member of the early management team at LensCrafters as it emerged from start-up to market leader. These businesses each solved real problems for patients and users and those are the kind of opportunities he seeks as he thinks about opportunities at HealthQuest. He graduated from Georgia Tech with a BS in Management Science. He spent the first half of his career in consumer products marketing, starting in brand management at Procter & Gamble in Cincinnati.